Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Sanofi : $621.13 Million Federal Contract Awarded to Sanofi Pasteur

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/12/2019 | 02:42am EST

ATLANTA, Georgia, Jan. 11 -- Sanofi Pasteur Inc., Swiftwater, Pennsylvania, won a $621,134,986 federal contract from the U.S. Department of Health and Human Services' Centers for Disease Control and Prevention for pediatric influenza vaccines.

Agency contacts: Monica D. Shaw, 770/488-8213, monica.shaw@cdc.hhs.gov; or Pellumbeshe Hoxhaj, 770/488-2805, kfx2@cdc.gov. CIV5FCA5. CLASS65; NAICS325412.

For more information about Targeted News Service's products, including its daily federal contract report, please contact: Myron Struck, Myron@targetednews.com, Editor, Targeted News Service LLC, Springfield, Va., Direct: 703/866-4708, Cell: 703/304-1897.

© 2019 Targeted News Service, source News Service

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SANOFI
01/19SANOFI : invests 80m and extends collaboration agreement with BioNTech
AQ
01/18LEXICON PHARMACEUTICALS : Stock Trading Halted Today, FDA Advisory Committee to ..
AQ
01/18TODAY'S LOGISTICS REPORT : Rerouting for Brexit; Reeling Smartphone Suppliers; B..
DJ
01/18LEXICON PHARMACEUTICALS : Stock Trading Halted Today; FDA Advisory Committee to ..
AQ
01/17Sanofi/Lexicon Diabetes Drug Gets 8-8 Vote From FDA Panel -- Update
DJ
01/17UNBEARABLE' : European Firms Face Brexit Uncertainty -- Update
DJ
01/17Sanofi/Lexicon Diabetes Drug Gets 8-8 Vote From FDA Panel
DJ
01/17SANOFI : FDA advisory committee votes on Zynquista(TM) (sotagliflozin) as treatm..
GL
01/17UNBEARABLE' : European Firms Face Brexit Uncertainty -- 2nd Update
DJ
01/17UNBEARABLE' : European Firms Face Brexit Uncertainty -- Update
DJ
More news
Financials (€)
Sales 2018 34 998 M
EBIT 2018 8 558 M
Net income 2018 5 040 M
Debt 2018 16 751 M
Yield 2018 4,22%
P/E ratio 2018 17,14
P/E ratio 2019 16,13
EV / Sales 2018 3,08x
EV / Sales 2019 2,95x
Capitalization 90 960 M
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 82,7 €
Spread / Average Target 13%
EPS Revisions
Managers
NameTitle
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer & Executive Vice President
Ameet Nathwani Executive Vice President-Medical Affairs
John C. Reed Head-Global Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI-3.40%103 282
JOHNSON & JOHNSON1.27%350 508
PFIZER-2.57%246 674
NOVARTIS5.09%227 840
ROCHE HOLDING LTD.5.96%223 053
MERCK AND COMPANY-0.71%197 291